1D′Cunha J, Corfits AL, Herndon JE 2nd, et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage 1 non-small cell lung cancer:preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg, 2002,123:484-491.
2Mountain CF. Revisions in international system for staging lung cancer. Chest, 1997,111:1710-1717.
3Ahrendt SA, Yang SC, Wu L, et al. Molecular assessment of lymph nodes in patients with resected stage 1 non-small cell lung cancer : preliminary results of a prospective study.J Thorac Cardiovasc Surg, 2002,123:466-473.
4Passlick B, Pantel K, Kubuschok B, et al. Expression of MHC molecules and ICAM-1 on non-small cell lung carcinoma: association with early lymphatic spread of tumor cells. Eur J Cancer, 1996,32:141-145.
5Kwiatkowski DJ, Harpole DH Jr, Godleski J, et al. Molecular pathologic substaging in 244 stage 1 non-small cell lung cancer patients: clinical implications. J Clin Oncol,1998,16:2468-2477.
6Pastorino U, Andreola S, Tagliabue E, et al. Immunocytochemical markers in stage 1 lung cancer: relevance to prognosis. J Clin Oncol, 1997,15:2858-2865.
7Passlick B, Izbicki JR, Kubuschok B, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer. J Clin Oncol, 1994,12:1827-1835.
8D'Amico TA, Aloia TA, Moore MB, et al. Predicting to sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg, 2001,72:1144-1148.
9Kim DH, Nelson HH, Wiencke JK, et al. Promoter methylation of DAP-kirase: association with advanced stage in non-small cell lung cancer. Oncogene, 2001,20:1765-1770.
10Salerno CT, Frizelle S, Niehans G, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.Chest,1998,113:1526-1532.
3Jiao X,Krasna MJ.Clinical significance of mierometastases in lung and esophageal cancer:a new paradigm in thoracic oncolngy.Ann Thorac Surg,2002,74:278-284.
4D'cunha J,Corfits AL,Hernden JE,et al.Molecular staging of lung cancer:real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage 1 non-small cell lung cancer.J Thorac Cardiovas Surg,2002,123:484-491.
5Hashimoto T,Kobayesh Y,Ishikawa Y,et al.Prognostic value of genetically diagnosed lymph node micrometnstasis in non-small-cell lung cancer cases.Cancer Res,2000,60:6472-6478.
6Pulte D,Li E,Crawford BK,et al.Sentinel lymph node mapping and molecular stasing in non-small cell lung carcinoma Cancer,2005,104:1453-1461.
7Marchevsky AM,Qiao JH,Krajisnik S,et al.The prognostic significance of intro-uodal isolated tumor cells and micrometasteses in patients with non-small cell lung carcinoms J ThoracCardiovasc Surg,2003,126:551-557.
8Gu CD,Osaki T,Oyama T,et al.Detection of micrometastatic tumor cells in pN0 lymph node of patients with completely resected no-small-cell lung cancer:impact on recurrence and survival Ann Surg,2002,235:133-139.
9Lau CL,Moore MB,Brooks KR,et al.Molecular staging of lung and esophageal cancer.Surg Clin North Am,2002,82:497-523.
10Stasiak PC,Purkis PE,Leigh IM,et al.Keratins 19:predicatied a mino acid sequence and Broad tissue distribution suggest it evolved from keratinocyte keratins.J Invest Dermatol,1989,92:707-716.
